Sanofi Blocks COVID-19 Vaccine Trademark In EU

By Alex Baldwin ( November 14, 2025, 9:41 PM GMT) -- Sanofi's vaccine subsidiary has convinced officials at the European Union's Intellectual Property Office to block an Indian biopharma company's bid to trademark for 'Covaxin Bharat Biotech,' after arguing that consumers would likely confuse the trademark with its own tetanus vaccine Covaxis....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login